Skip to content
Loading...
All Sources
All Years

-

EASL Statement on Resmetirom FDA approval

After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of…

-

Tribute to Sir Roy Calne (1930-2024)

It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed…

Back To Top